The QualityStocks Daily Tuesday, July 10th, 2018

Today's Top 3 Investment Newsletters

StockMarketWatch (BLIN) +75.57%

The BullChaser (NRBT) +61.83%

StocksToBuyNow (PRVCF) +40.85%

The QualityStocks Daily Stock List

Maple Gold Mines Ltd. (MGMLF)

Jet Life Penny Stocks, OTC Markets, Stockwatch, Stockhouse, Dividend Investor, Wallet Investor, InvestorsHub, GuruFocus, MarketWatch, Wall Street Nation, 4-Traders, Junior Mining Network, TradingView, Barchart, and InvestorsHangout reported on Maple Gold Mines Ltd. (MGMLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Maple Gold Mines Ltd. is an exploration company centered on advancing a district-scale gold project in one of the world’s premier mining jurisdictions. Its 370 km2 Douay Gold Project is within the prolific Abitibi Greenstone Belt in northern Quebec. The Douay Gold Project has first-rate infrastructure with large operating mines within 150 kms. There is significant resource expansion and exploration upside at Douay.

Maple Gold Mines has its management office in Toronto, Ontario. The Company previously went by the name Aurvista Gold Corporation. It changed its name to Maple Gold Mines Ltd. in November of 2017. The Company lists on the OTC Markets Group’s OTCQB.

The Douay Project has an established gold resource, which remains open in manifold directions. Maple Gold is concentrating on expanding the known resource areas and testing new discovery targets within its 55 km of strike along the Casa Berardi Deformation Zone.

The updated resource estimate (NI 43-101 Technical Report - March 2018) successfully converted a major proportion of Inferred to the Indicated Resource category, at Douay West and Porphyry Zones. Resources at Douay now stand at 2.76 million ounces Inferred plus 0.48 million ounces Indicated

In late June, Maple Gold Mines reported additional drill results from the western half of the Porphyry Zone within the current Resource Area at the Douay Property. Within this area 8 infill and step-out holes were drilled in 2018. Assays are pending for the westernmost hole of these only.

Geological observations and assay results for these new holes show good continuity of mineralization in this area, with a number of higher grade intervals, within a syenite dyke or dyke swarm in the hanging wall of one of the Casa Berardi Faults.

Yesterday, Maple Gold Mines reported additional drill results from the eastern half of the Porphyry Zone within the current Resource Area at the Douay Project. Within this area 16 infill and step-out holes were drilled in 2018, with all assays now received. The main intercepts in DO-18-247 and DO-18-254 show considerably higher grades than adjacent holes. This indicates that grade may increase with depth in this area.

Maple Gold Mines’ President and Chief Executive Officer, Mr. Matthew Hornor, stated: "We continue to intersect new zones of mineralization and given the widely spaced drilling in this eastern part of the Resource Area there is still good potential to make additional discoveries with further drilling."

Maple Gold Mines Ltd. (MGMLF), closed Tuesday's trading session at $0.11, down 8.33%, on 48,080 volume with 14 trades. The average volume for the last 60 days is 177,222 and the stock's 52-week low/high is $0.0903/$0.27.

chart

Premier Holding Corp. (PRHL)

OTC Markets, InvestorsHub, Street Insider, Stockhouse, Investors Hangout, and StockFlare reported on Premier Holding Corp. (PRHL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Premier Holding Corp., by way of its subsidiaries, provides energy efficiency products and services. It does so mainly to commercial middle market companies and residential customers in the U.S. Premier provides financial support and management expertise. This includes access to capital, financing, legal, insurance, mergers, acquisitions, joint ventures (JVs) and management strategies. Listed on the OTCQB, Premier Holding has its corporate office in Tustin, California.

Premier Holding’s companies have wide-ranging experience in technologies and services for deregulated power and expertise in energy reduction. Fundamentally, its companies lower its clients’ price and usage of energy. Premier's mission is to acquire clean technology companies and/or green products and services, which are accretive and that can be seamlessly integrated and use the overall economics of such products and services for the benefit of its customers.

The Company’s holdings include The Power Company and E3 - Energy Efficiency Experts. The Power Company is an experienced energy consulting firm in the deregulation space. It uses its market standing and its large, well-established network of energy suppliers to compete for its clients’ business. The Power Company serves as its clients’ energy advocates. Moreover, it negotiates the most competitive pricing and options for its clients.

The Power Company received the "2017 Leaders Diamond" Award from a major deregulated power supplier. The award combines the volume of sales, connected with the sales of home products. It calculates this with a quality score by customers to create a "Sales Quality" Score. The team at TPC attained the highest score among all resellers for 2017.

E3 - Energy Efficiency Experts is an Energy Services Company (ESCO). E3 was created by Premier Holding to provide the best-of-breed energy reduction solutions for its customers. E3 works to provide the most current, fully-vetted solutions in energy reduction technologies. It also works to provide management tools that capture the client for future opportunities.

Today, Premier Holding announced that its subsidiary, The Power Company (TPC), supports another large commercial contract. This indicates its breadth of sales into the residential and commercial sectors. TPC continues to help manage and lessen the energy costs for one of the largest and fastest growing physical therapy companies in the nation.

Recently, TPC secured the energy supply for its customer's newest properties in Texas. This helps to manage an important business expense for its customer, while the company continues to expand through organic growth and acquisitions. In addition, this company is in talks to further help reduce its customer's energy costs through the implementation of LED lighting for its locations throughout the country via Premier’s energy efficiency division, E3 - Energy Efficiency Experts.

Premier Holding Corp. (PRHL), closed Tuesday's trading session at $0.03, even for the day. The average volume for the last 60 days is 91,334 and the stock's 52-week low/high is $0.0136/$0.06.

chart

iCo Therapeutics, Inc. (ICOTF)

TheMicrocapNews, Wall St Report, OTC Markets Group, and Vantage Wire reported earlier on iCo Therapeutics, Inc. (ICOTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

iCo Therapeutics, Inc. identifies existing development stage assets for use in underserved ocular and infectious diseases. The Company owns the international exclusive rights to an oral delivery system - Amphotericin B (Amp B) - for life-threatening infections. Amphotericin B is the gold standard for systemic antifungal drugs. It is one example of a well-established, highly efficacious systemic antifungal drug that has a 50-year history of intravenous therapy.

iCo Therapeutics has its headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

iCo Therapeutics’ concentrates its efforts on development instead of research. Its business model aims to acquire the rights to drugs, which are either off-patent, currently approved or near commercialization, and develop them through redosing or reformulating them for new or expanded labels.

The existing development stage assets that iCo identifies may exhibit utility in non-ophthalmic conditions outside iCo Therapeutics’ core emphasis areas. If so, the Company will look to capture further value by way of partnerships, such as its partnership with Immune Pharmaceuticals (IMNP), which is in several Phase 2 studies involving iCo-008.

iCo-008 is also known as Bertilimumab or CAT-213. It is a human monoclonal antibody targeting eotaxin-1, a member of the chemokine family of proteins that acts as a messenger between the cells of the immune system. Immune Pharmaceuticals initiated a Phase 2, double-blind, placebo controlled study with iCo-008 in 90 patients with moderate-to-severe ulcerative colitis.

In 2016, iCo Therapeutics continued to advance its Oral Amphotericin B Delivery System (Oral Amp B), undertaking pre-clinical pharmacokinetic and distribution studies utilizing its optimized formulations. It stated that data from these studies support the further development of its Oral Amp B with once a day dosing possible in certain indications.

This past November, iCo Therapeutics, and its recently formed subsidiary iCo Therapeutics Australia Pty Ltd., announced that it was granted ethics approval in Australia to conduct its proposed Phase 1 clinical study for Oral Amphotericin B.

Amphotericin B is a well-known approved drug for the treatment of fungal and parasitic infections. However, the therapy is presently limited by intravenous infusion. iCo Therapeutics is developing a proprietary oral reformulation of Amphotericin B.

The Phase 1 Clinical Trial is a randomized, double-masked, placebo-controlled, single dose ascending study. It is to assess the safety, tolerability, and bioavailability of iCo-019 (Oral Amphotericin B) in healthy male and non-pregnant female subjects between 18-55 years of age.

Subjects will be randomized into one of four cohorts. Each cohort will represent an ascending single dose of treatment.

iCo Therapeutics, Inc. (ICOTF), closed Tuesday's trading session at $0.1613, up 33.42%, on 201,846 volume with 35 trades. The average volume for the last 60 days is 45,533 and the stock's 52-week low/high is $0.02/$0.1582.

chart

InnerScope Hearing Technologies, Inc. (INND)

InvestorsHub, Front Page Stocks, YCharts, Stockhouse, Stockopedia, and MarketWatch reported on InnerScope Hearing Technologies, Inc. (INND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

InnerScope Hearing Technologies, Inc. is a technology driven enterprise with highly scalable B2B (Business-to-Business) and B2C (Business-to-Consumer) solutions. The Company has plans on opening, operating, and expanding a chain of audiological and retail hearing device clinics. Headquartered in Roseville, California, InnerScope Hearing Technologies lists on the OTC Markets Group’s OTCQB. The Company incorporated in June of 2012.

Last month, InnerScope Advertising Agency, Inc. announced its name change to InnerScope Hearing Technologies, Inc. This change was completed and approved by FINRA (Financial Industry Regulatory Authority). The change was effective September 18, 2017. InnerScope continues trading under the OTCQB ticker symbol: INND.

InnerScope’s updated business plan is to scale its infrastructure to develop and deploy a revenue eco-system strategy. This includes expanding the revenue model to other major sectors of the international hearing industry. It recently announced plans to acquire AUDserv, Inc.

InnerScope will create seven separate revenue generating divisions. The Company said that each division will generate revenue and be positioned for growth, thereby increasing InnerScope’s market penetration.

InnerScope provides a B2B SaaS (Software as a Service) based Patient Management System (PMS) software program. The design of this is to improve operations and communication with patients. In addition, the Company offers a Buying Group experience for audiology practices. This enables owners to reduce product costs and grow their margins.

Furthermore, InnerScope Hearing Technologies will compete in the DTC (Direct-to-Consumer) markets with its own line of "Hearables," and "Wearables" and cutting-edge Apps on the iOS and Android markets. In essence, the Company’s corporate mission is to innovate and deploy products and services on a scalable platform for the 360-plus million people around the Global Suffering from Hearing Impairment to create an Eco-System around the Company.

This month, InnerScope Hearing Technologies announced that it is entering into a supply and distribution agreement with Blue-Gear, Inc. This agreement is for global rights of Blue-Gear's Personal Sound Amplifier Products (PSAP). Blue-Gear's technical team will also be working with InnerScope Hearing Technologies employees to develop its own line of PSAP devices for worldwide distribution.

Additionally, this month, InnerScope announced its preferred vendor status with Samplified International BV. Samplified's U.S. subsidiary, Samplified-Audio LLC (Samplified US), headquartered in Boulder, Colorado, was recently announced the winner of the National Science Foundation's "National Hearables Challenge" for its Clementine Wear Audio Software Platform.

Samplified has developed "SnowOwl." This is its initial product utilizing the Clementine Wear platform. SnowOwl is a programmable audio companion for personalized sound experience in any situation. SnowOwl is the first hearable and wearable product with Clementine Wear built inside.

InnerScope Hearing Technologies, Inc. (INND), closed Tuesday's trading session at $0.0074, up 5.71%, on 555,533 volume with 22 trades. The average volume for the last 60 days is 306,623 and the stock's 52-week low/high is $0.0069/$1.50.

chart

Ipsidy, Inc. (IDTY)

Investors Hangout, InvestorsHub, Investopedia, TradingView, Proactive Investors, Barchart, Stockwatch, Simply Wall St, OTC Markets, Stockhouse, 4-Traders, and Penny Stock Hub reported on Ipsidy, Inc. (IDTY), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Ipsidy, Inc. is a provider of secure, biometric identification, identity management and electronic transaction processing services. The Company’s identity transaction platform creates a trusted transaction, embedding authenticated identity and event details with a digital signature and using a participant's mobile device to approve everyday transactions.

Established in 2009, Ipsidy is based in Long Beach, New York. The Company lists on the OTC Markets OTCQX. It formerly went by the name ID Global Solutions Corporation. It changed its name to Ipsidy, Inc. in February 2017.

The Company’s platform is undergoing design to use biometric and multi-factor identity management solutions intended to support a wide spectrum of electronic transactions. Ipsidy’s belief is that it is critical that businesses and consumers know who is on the other side of an electronic transaction and have an audit trail, proving that the identity of the other party was properly authenticated.

Ipsidy’s identity transaction platform aims to help its customers more rapidly and effectively secure their citizens, employees, customers and associated physical and digital transactions, and promote a more secure, globally connected world. The Company’s identity platform enables mobile users to more easily authenticate their identity to a mobile phone or portable device of their choosing.

Ipsidy has two operating subsidiaries: MultiPay in Colombia, (www.multipay.com.co); and Cards Plus in South Africa, (www.cardsplus.co.za).

In late June, Ipsidy and Skypatrol LLC announced that they agreed to offer SkyGuru. SkyGuru combines Skypatrol's GPS technology with Ipsidy's Transact digital issuance platform and mobile biometrics to deliver integrated cost-control and expense management to trucking fleet operators and logistics companies across the Latin American market. Skypatrol is a provider of unique GPS-tracking and fleet-management software tools.

SkyGuru is powered by Ipsidy's Transact digital issuance platform providing the Ipsidy Mobile Wallet. This wallet is a virtual payment account for mobile devices. The fleet's drivers download the Ipsidy Mobile Wallet. They subsequently proceed to make their purchases of fuel or other services at participating gas station and other merchants, to which Skypatrol's systems can specifically route them.

Ipsidy, Inc. (IDTY), closed Tuesday's trading session at $0.2005, down 8.86%, on 349,353 volume with 15 trades. The average volume for the last 60 days is 257,800 and the stock's 52-week low/high is $0.09/$0.365.

chart

United Cannabis Corp. (CNAB)

Actual Gains, Broad Street, TopPennyStockMovers, OTCBB Journal, StocksImpossible, Cannabis Financial Network News, PricelessPennyStocks, PennyStockRumors.net, Stockgoodies, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Market Intelligence Center Alert, Marketbeat.com, StreetAuthority Daily, Money Map Press, MyBestStockAlerts, and Wall Street Wolves reported on United Cannabis Corp. (CNAB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s dedication is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. The Company formed to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, and services. A biotechnology enterprise, the Company is the creator of Prana Bio Nutrient Medicinals. United Cannabis is based in Denver, Colorado.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. The Company owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products. It has established affiliate relationships with Harborside Health Center of California, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, and Cannabinoid Research & Development (CRD).

The United States Patent and Trademark Office (USPTO) has issued US Patent #9730911, granting exclusive rights to United Cannabis’ proprietary formulations based on compounds extracted from cannabis plant materials. More precisely, it is the composition of matter regarding the use of phytocannabinoids, cannabinoids, and specific terpene profiles in liquid form. This composition of matter patent provides protection for the Company’s proprietary formulations.

United Cannabis’ A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a comprehensive solution designed to allow physicians and patients to implement and monitor effective therapy protocols. Prana Bio Nutrient Medicinals is a total, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and numerous non-abrasive delivery methods.

The A.C.T. Now program provides affordable patient driven programs with limitless combinations of cannabinoid-based products. Moreover, it provides nutritional recommendations to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many kinds of cancer.

Prana Bio Nutrient Medicinal products provide patients a way to mix/match cannabinoids for therapeutic purposes. These products are licensed to regulated marijuana dispensaries. The Company employs an infusion process using select fatty acids, lipids, and specific combinations of cannabis derived terpenes to increase bioavailability.

In July 2017, United Cannabis announced the acquisition of a majority share of Prana Therapeutics, Inc. (PTI). Prana is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopedic markets. Prana concentrates on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis, and treatment of brain cancer.

This month, United Cannabis announced that Jamaica's Ministry of Health registered the Company’s Prana CBD-Infused Water as a medicinal cannabis product. The Prana Water will be manufactured and distributed by United Cannabis’ Jamaican subsidiary, Cannabinoid Research & Development Limited (CRD).

CRD has commenced preliminary work to initiate production of other United Cannabis products in Jamaica. This includes its Prana P5 Hemp Bio Nutrient Capsules, Aromatherapy Roll-On, as well as Sublingual Drops.

United Cannabis Corp. (CNAB), closed Tuesday's trading session at $0.6911, up 1.63%, on 205,533 volume with 123 trades. The average volume for the last 60 days is 170,001 and the stock's 52-week low/high is $0.552/$2.50.

chart

Katanga Mining Limited (KATFF)

OTC Markets, Stockwolf, Insider Financial, Stockhouse, 24hGold, The Street, InvestorsHub, 4-Traders, and Stockwatch reported on Katanga Mining Limited (KATFF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Katanga Mining Limited, by way of its subsidiary, Kamoto Copper Company SA, engages in copper and cobalt mining and related activities in the Democratic Republic of Congo (DRC). The Company operates a large-scale copper-cobalt project with substantial high-grade mineral reserves and integrated metallurgical operations in the DRC. Katanga Mining is based in Whitehorse, Yukon Territory and also has offices in Zug, Switzerland, and Johannesburg, South Africa.

The Company operates a large-scale copper-cobalt mine complex in the DRC through two joint ventures (JVs). These are Kamoto Copper Company (KCC) and DRC Copper and Cobalt Project (DCP). Katanga Mining’s assets include the Kamoto Underground Mine and KOV open pit mine. These provide sulfide and oxide ores, respectively.

In addition, Katanga Mining’s assets include the Kamoto Concentrator and Luilu Metallurgical Plant for the onsite production of refined copper and cobalt. The Company also has a number of other mines and plants. The Kamoto Project commenced commercial production on June 1, 2008.

For this year, Katanga Mining’s production guidance is 150,000 tonnes and 11,000 tonnes of copper cathode and cobalt contained in hydroxide, respectively.

Katanga Mining was notified on April 20, 2018 that its JV partner, the Democratic Republic of Congo (DRC) state-owned La Générale des Carrières et des Mines (Gécamines), in the Company’s 75 percent DRC operating subsidiary Kamoto Copper Company (KCC), started legal proceedings in the DRC to dissolve KCC.

This is following KCC’s failure to address its earlier disclosed capital deficiency or, alternatively, if the Court provides KCC with a period of time within which to regularize the situation, to request the appointment of an expert to assess and report to the Court on KCC’s financial position and the recapitalization plan. Katanga Mining believes that it has several options to resolve KCC’s capital deficiency and avoid KCC’s dissolution.

Katanga Mining announced that Ventora Development Sasu, a company affiliated with Mr. Dan Gertler, on April 27, 2018, served in the DRC a freezing order against Kamoto Copper Company (KCC) in the amount of US$2.28 billion.

The freezing order authorizes the bailiff of the Commercial Court of Kolwezi to freeze certain bank accounts, tangible movable assets, and intangible movable assets, including receivables of KCC, and the mining titles, up to the amount of the freezing order and prevent KCC from disposing and/or utilizing these assets.

Katanga Mining Limited (KATFF), closed Tuesday's trading session at $0.72174, down 2.08%, on 41,133 volume with 38 trades. The average volume for the last 60 days is 223,507 and the stock's 52-week low/high is $0.397/$2.25.

chart

Rise Gold Corp. (RYES)

StockChase, MarketWatch, Marketwired, 4-Traders, OTC Markets, Stockhouse, and Streetwise Reports reported on Rise Gold Corp. (RYES), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rise Gold Corp. is an exploration-stage mining company listed on the OTCQB. Its chief asset is the historic past producing Idaho-Maryland (I-M) Gold Mine situated in California. The Idaho-Maryland Mine was a significant past producer, yielding 2.4M oz of gold. Rise Gold has its corporate office in Vancouver, British Columbia.

The Idaho-Maryland Gold Mine property is fully-owned by Rise Gold. This includes surface and mineral rights. The Company owns all the mineral rights. This Mine is near Grass Valley, California.

The Idaho-Maryland Gold Mine produced a total of 2,414,000 oz gold with an average mill head grade of 0.50oz/ton (about 17g/t). The Mine was producing up to 129,000 oz gold per year before being forced to shut down by the U.S. government in 1942. During WW II the U.S. War effort wanted to shut down precious metals excavation and shift the national mining workforce from gold to copper production.

Recently, Rise Gold announced it completed the purchase of 82 acres of fee-simple land (Mill Site Property) contiguous to the historic New Brunswick mine shaft. Total payments to acquire an undivided 100 percent interest in the Mill Site Property were US$1,900,000.

Rise Gold has invested US$3,900,000 for the purchase of private land in Nevada County, California. It bought the Mill Site Property to support the exploration and future development of the Idaho-Maryland (I-M) Gold Project.

Last month, Rise Gold announced it purchased two diamond core drilling rigs for exploration at the Idaho-Maryland (I-M) Gold Project. The Company purchased a powerful deep hole rig (Rig #1) capable of drilling HQ-size core to depths up to 2,050 m (6,750 ft) and NQ-size core to depths up to 2,745 m (9,000 ft). In addition, it purchased a smaller drill rig (Rig #2) that will undergo modification by Rise Gold to attain depths with NQ-size core up to 900 m (2,950 ft).

In late June, Rise Gold announced assay results from continuing diamond core drilling at the Idaho-Maryland (I-M) Gold Project. Highlights include new drill intercepts assay up to 7.9 gpt gold over 4.4 m & 8.0 gpt gold over 4.0 m.

Six Brunswick veins have been tested-to-date and visible gold observed in core samples. The drilling confirms continuation of Brunswick veins below historic mining on the B1600 level.

Drill hole B-18-05 is in progress and presently at 800 m depth, testing below the B2300 level. Moreover, quartz veins, breccia, and stockwork were intersected in B-18-05 with assays in progress.

Rise Gold Corp. (RYES), closed Tuesday's trading session at $0.067, even for the day. The average volume for the last 60 days is 45,672 and the stock's 52-week low/high is $0.0625/$0.165.

chart

Sustainable Projects Group, Inc. (SPGX)

OTC Markets, Market Exclusive, MarketWatch, and OilandGas360 reported on Sustainable Projects Group, Inc. (SPGX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sustainable Projects Group, Inc. is a member of SP Group. Sustainable Projects is positioned to become a world leading natural resources holding and development enterprise via value-based investments and collaborative partnerships with worldwide leaders across the natural resources sector. SP Group has initiated its goals through pursuing investment and partnerships with some of the most diversified and integrated companies available on the market.

Sustainable Projects Group is headquartered in Naples, Florida. The Company lists on the OTC Markets Group’s OTCQB.

The Company is to invest into undervalued international companies through direct investment. Additionally, it is negotiating investment and collaboration agreements with different global leaders throughout the natural resource industry.

SP Group’s dedication is to negotiating working interests (WIs) in a wide variety of natural resource projects around the world. It uses the local knowledge and expertise of companies that operate its interests. Therefore, it benefits as non-operators from low-risk opportunities to provide a steady stream of resources to the worldwide market.

SP Group chooses its investments and partnerships only from well established companies with a proven record of accomplishment and that bring strong project experience to the Company. Currently, it is invested in a range of natural resources projects beyond its initial focus on oil and gas. It has plans to considerably add to the portfolio over the coming years.

In December of 2017, Sustainable Projects Group announced the acquisition of myfactor.io AG. This is a business development enterprise headquartered in Liechtenstein.

Sustainable Projects Group is gaining direct access to a company with the experience and infrastructure to develop SME's and issue bonds. This will allow Sustainable Projects Group to further extend the range of consulting and business development expertise represented within the Company. As part of its growth strategy for SME's, myfactor.io can place bonds in US Dollars, Euros and Swiss Francs.

In February of this year, Sustainable Projects Group announced the acquisition of a 10 percent stake in Falcon Projects AG.  Falcon specializes in bridge financing and refinancing solutions in the construction and project development industry. With the acquisition, Sustainable Projects Group continues to widen its network of investments and partners in different industries.

Recently, Sustainable Projects Group announced that Stefan Muehlbauer, who has previously served as the Company's Chief Financial Officer (CFO) was appointed to Chief Executive Officer (CEO). Christian Winzenried who has served as the Company's CEO since 2017 was named CFO..

Sustainable Projects Group, Inc. (SPGX), closed Tuesday's trading session at $4.35, up 9.02%, on 118 volume with 1 trade. The average volume for the last 60 days is 2,057 and the stock's 52-week low/high is $2.60/$6.00.

chart

Blue Sphere Corp. (BLSP)

Fast Money Alerts, Stock Shock and Awe, PremiereStockAlerts, DreamTeamNetwork, MyBestStockAlerts, OTPicks, Penny Stock General, PennyStocks24, and SmallCapVoice reported earlier on Blue Sphere Corp. (BLSP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Blue Sphere Corp. is a global Independent Power Producer (IPP). The Company is working to become a key player in the international waste-to-energy and renewable energy markets. It has a business plan that fits the changing regulatory standards for waste and energy.

A clean-technology waste-to-energy producer, Blue Sphere’s primary business model is BOO (Build-Own-Operate) - long-term energy agreements are executed with electric companies in advance of projects. Blue Sphere has its headquarters in Charlotte, North Carolina. A waste-to-energy project integrator, the Company has operations in the United States, Israel, and Europe. Blue Sphere lists on the OTC Markets’ OTCQB.

Blue Sphere is performing waste-to-energy projects in the United States and Italy. It is pursuing a strategy to work in association with landfill owners to convert harmful methane gas emissions from landfills into electricity. The process is established on readily available technology already being used in different parts of the United States and other areas globally.

Blue Sphere has its Charlotte, North Carolina Waste to Energy Anaerobic Digester 5.2 MW Plant. In Johnston, Rhode Island, the Company has its Waste to Energy Anaerobic Digester 3.2 MW Plant.

Blue Sphere, by way of its wholly-owned subsidiaries, completed the acquisition of four operating biogas the Company’s history. Blue Sphere acquired 100 percent of the stock of Agricerere, S.R.L., Agrielektra, S.r.L., Agrisorse, S.r.L. and Gefa, S.r.L.

Individually, each fully operational facility produces one megawatt of electricity per hour, which sells to Gestore del Servizi Energetici GSE, S.p.A., a state owned company that promotes and supports renewable energy sources in Italy, under a Power Purchase Agreement (PPA) that runs through December 31, 2027.

Last month, Blue Sphere provided an update on activities for its projects in Udine, Italy and Sterksel, Netherlands. In Udine, Italy, Blue Sphere has realized its goal and the facility is operating at 95 percent of capacity as of November 5, 2017.

For Sterksel, Netherlands, the Company has met important milestones in the development of its landmark project in Holland. On December 4, 2017, Blue Sphere entered into a definitive EPC agreement with Anergia B.V. The agreement includes a turnkey agreement for the design, construction and delivery of a Biogas Plant, a service, maintenance and operation Agreement and a performance guarantee.

Blue Sphere Corp. (BLSP), closed Tuesday's trading session at $0.201, even for the day, on 218,700 volume with 19 trades. The average volume for the last 60 days is 40,048 and the stock's 52-week low/high is $0.1901/$2.75.

chart

GeoVax Labs, Inc. (GOVX)

Stock Stars, DrStockPick, HotOTC, Wall Street Resources, Stock News Now, SmallCapStockPlays, ProActive Capital, IRGnews Alert, PennyOmega, CoolPennyStocks, FeedBlitz, SmallCapVoice, M2 Communications, Standout Stocks, Stockpalooza, PennyTrader.com, Penny Performers, and Investor Place reported on GeoVax Labs, Inc. (GOVX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

GeoVax Labs, Inc. is a clinical-stage biotechnology company listed on the OTCQB. It is developing human vaccines against infectious diseases employing its MVA-VLP vaccine platform. The Company’s vaccine platform supports in vivo production of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. Established in 2001, GeoVax Labs is based in Smyrna, Georgia.

The Company’s development programs center on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, and also therapeutic vaccines for chronic Hepatitis B infections and cancers. Regarding VLPs, the production of VLPs in the person undergoing vaccination mimics a natural infection, stimulating the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection should it appear.

Clinical trials for GeoVax’s preventive HIV vaccines have been conducted by the NIH-supported HIV Vaccine Trials Network (HVTN) with financing from the National Institute of Allergy and Infectious Diseases (NIAID). All together, the Company’s HIV vaccines, in diverse doses and combinations, have been tested in 500 humans with very encouraging results.

In December, GeoVax Labs announced that it is collaborating with the U.S. Naval Research Laboratory (USNRL). This collaboration is to develop high-quality antibodies useful for detection of Lassa virus (LASV), and potentially as a treatment for Lassa Fever (LF). Lassa Fever is an acute viral hemorrhagic illness caused by LASV. A member of the Arenavirus family, LASV causes severe and often fatal hemorrhagic illnesses in West Africa.

Earlier this month, GeoVax Labs announced that it is collaborating with Vaxeal Holding SA on the expansion of GeoVax’s cancer immunotherapy program. The foundation of GeoVax’s immuno-oncology program is on its Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform that produces non-infectious VLPs in the individual being vaccinated.

This collaboration between GeoVax Labs and Vaxeal Holding will include the design, construction, characterization and animal testing of vaccine candidates utilizing GeoVax’s MVA-VLP vaccine platform. Vaccine antigens will include Vaxeal’s proprietary designed sequences. Vaxeal Holding SA (Vevey, Switzerland), in partnership with foremost international research institutes, is developing therapeutic vaccines in combination with immuno-modulatory drugs for the treatment of cancers and infectious diseases.

Last week, GeoVax Labs announced the publication of its manuscript entitled “A Single-Dose of Modified Vaccinia Ankara Expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge.” The paper is published in the peer-reviewed open access journal Scientific Reports by Nature Research. The Company’s Ebola vaccine (GEO-EM01) is founded on the Company’s novel Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform. This platform produces noninfectious VLPs in the individual undergoing vaccination.

Farshad Guirakhoo, PhD, Chief Scientific Officer of GeoVax Labs, said, “GEO-EM01 uses GeoVax’s proven MVA-VLP vaccine platform that has been shown to be safe and to induce durable antibody and T-cell responses in multiple human clinical trials for GeoVax’s prophylactic HIV vaccine. Using the same platform, we have shown our Zika vaccine (GEO-ZM02) and our Lassa Fever vaccine (GEO-LM01) to provide single-dose 100 percent protection in mice against intracranial challenge.``

GeoVax Labs, Inc. (GOVX), closed Tuesday's trading session at $0.0385, up 3.49%, on 395,070 volume with 24 trades. The average volume for the last 60 days is 565,964 and the stock's 52-week low/high is $0.0248/$0.1049.

chart

Greystone Logistics, Inc. (GLGI)

Zacks, Trading View, and MarketWatch reported on Greystone Logistics, Inc. (GLGI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Greystone Logistics, Inc. reprocesses and sells recycled plastic, and designs, manufactures, sells, and leases high-quality 100 percent recycled plastic pallets. These provide logistical solutions needed by a broad assortment of industries. These industries include food and beverage, agricultural, automotive, chemical, and pharmaceutical and consumer products. A "Green" manufacturing and leasing enterprise, Greystone Logistics has its corporate office in Tulsa, Oklahoma.

Greystone Logistics is the largest 100 percent recycled plastic pallet manufacturer in the U.S. The Company provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.

Greystone Logistics technology, including that used in its injection molding equipment, and its proprietary blend of recycled plastic resins and patented pallet designs, enables speedy production of high-quality pallets and at lower costs than numerous processes. The recycled plastic for its pallets helps control material costs. This is while reducing environmental waste.

Greystone’s products include rackable, nestable, display, monoblock, and stackable pallets. Furthermore, the Company’s products include picture frame web-top pallets and web-top pallets. Greystone also sells recycled plastic that undergoes reprocessing into pellet form. It also provides pallet leasing services.

Greystone Logistics offers recycled pallets for sale including full picture frame and three skids models and IBC pallets. Plastic pallets last 10-50 times longer than wood; have residual (trade-in) value; are recyclable; have a high coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact; have substantially lower life cycle costs (cost per trip) and are suited for closed loop systems.

This past April, Greystone Logistics reported that Sales for the three months ended February 28, 2018 totaled $12,064,651 versus $8,693,851 for the prior period. This represents an increase of $3,370,800, or 39 percent.

Sales for the nine months ended February 28, 2018 were $32,073,828 versus $25,759,823 for the prior period. This represents an increase of $6,314,005, or 25 percent.

Net Income was $5,546 versus $920,883 for the three months ended February 28, 2018 and 2017, respectively, and $679,899 versus $1,133,317 for the nine months ended February 28, 2018 and 2017, respectively.

Greystone Logistics, Inc. (GLGI), closed Tuesday's trading session at $0.45, even for the day, on 24,000 volume with 3 trades. The average volume for the last 60 days is 26,657 and the stock's 52-week low/high is $0.33/$0.60.

chart

Mechanical Technology, Inc. (MKTY)

PinnacleDigest, StockOodles, SmarTrend Newsletters, and RedChip reported earlier on Mechanical Technology, Inc. (MKTY), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Mechanical Technology, Inc. engages in the design, manufacture, and sale of test and measurement instruments and systems. These instruments and systems provide solutions for precision linear displacement, vibration measurement and balancing, and wafer inspection tools developed for markets that require the exacting measurement and control of products and processes in the development and implementation of automated manufacturing, assembly, and steady operation of complex machinery. Formed in 1961, Mechanical Technology has its corporate office in Albany, New York.

The Company conducts its work by way of its wholly-owned subsidiary, MTI Instruments, Inc. MTI Instruments’ products use a complete collection of technologies to solve complex, real world applications in numerous industries. These industries include manufacturing, electronics, semiconductor, solar, commercial and military aviation, automotive, and data storage.

MTI Instruments has an acquisition-based growth strategy. MTI is targeting for acquisition companies with $10 million to $30 million in annual revenues; and $2 million to $10 million in Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA).

MTI is also targeting for acquisition companies that manufacture precision test and measurement sensors, instruments, and systems used in automated manufacturing and assembly and consistent operation of complex machinery. In addition, it is targeting companies that concentrate on aerospace, semiconductor, electronics, automotive and/or general industrial sectors.

MTI Instruments’ test and measurement segment has three product groups. These are: Precision Instruments; Semiconductor and Solar Metrology Systems; and Balancing Systems. MTI is an international supplier of precision linear displacement solutions, vibration measurement and system balancing solutions, and wafer inspection tools.

MTI Instruments has its 2D/3D line of laser scanners. The ProTrak™ 2D/3D line of products are advanced, high resolution, high speed profiling sensor product lines for use in industrial, robotic, as well as manufacturing settings. The ProTrak series uses laser triangulation principles.

MTI Instruments serves the industrial manufacturing/production markets, and the research, design and process development market. Furthermore, it serves tensile stage systems for materials testing at academic and industrial research settings; and engine vibration analysis systems for military and commercial aircraft.

Regarding its Vibration and Balancing Systems, MTI Instruments has its PBS-4100+ Portable Vibration and Balancing System. The design of this portable vibration analysis and engine trim balance system for commercial and military aviation is to rapidly pinpoint engine problems and eliminate avoidable engine removals.

Mechanical Technology, Inc. (MKTY), closed Tuesday's trading session at $0.6499, up 7.87%, on 3,131 volume with 5 trades. The average volume for the last 60 days is 3,122 and the stock's 52-week low/high is $0.5701/$1.18.

chart

Umatrin Holding Limited (UMHL)

MarketWatch, OTC Markets, and BusinessWire.com reported on Umatrin Holding Limited (UMHL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Umatrin Holding Limited sells and trades in beauty, personal care, health, and wellness products. It does so primarily in Malaysia. The Company markets its products to end-users and dealers via an online channel and a retail store. U Matrin Worldwide Sdn Bhd (270883-X) is a subsidiary of Umatrin Holding Limited. U Matrin Worldwide is based in Kuala Lumpur.

The Company Incorporated in the state of Delaware on February 2, 2005. Umatrin has 10 years’ experience in Internet performance and security.

Umatrin Holding originally incorporated to locate and negotiate with a targeted business entity for the combination of that target company with Umatrin Holding. To move forward with this vision, on January 6, 2016, Umatrin decided to acquire an operating company in Malaysia, called U Matrin Worldwide Sdn Bhd, into Umatrin Holding Limited. U Matrin Worldwide Sdn Bhd was awarded with a direct selling license by the Ministry of Domestic Trade and Consumer Affairs in Malaysia.

Umatrin Holding operates in greater than 25 nations and territories. It operates leading O2O (Online to Offline) marketplaces in the retail and wholesale trade.

Umatrin provides technology and services to enable consumers, merchants, and other participants to conduct business in its cloud ecosystem. Umatrin Holding has over five years’ experience in managing e-commerce sites, brand marketing, product development, as well as financial security.

For Home Appliances, Umatrin’s products include the Hyundai Waco Water Filter and the Hydrogen Alkaline Water Stick. For Healthcare, the Company offers the Nano Patch. This product is for maintaining a constant level of nutrients in the blood.

Umatrin is using advanced network technology and a strong management system that creates unlimited business brand space. The Company continuously introduces new products and combined O2O internet business model and career opportunities, which do not require huge sums of operating cost.

Umatrin has its Akero Secret product. Akero Secret is developed with 100 percent natural botanical active ingredients. It is a beauty product for clean and clear skin. The Akero Gold Series consists of Gold Toner, Gold Moisturizer, Gold Magical Cream, and Gold Cleanser.

The Company’s products also include Unibersih. This is an herbal essence used for the treatment of constipation, pigmentation, overweightness, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, and more. Unibersih is a natural unpolluted herbal essence based Health Food Supplement. It is manufactured by GMP factories.

Moreover, Umatrin provides Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; nano anti-aging face serum, nano eye contour serum, nano collagen face serum, nano whitening face serum, and nano vibration serum pen.

In addition, the Company offers its Akero Deep Cleanse Shampoo. This shampoo has three main ingredients. These are Pro Vitamin B5, Coconut Oil, and Guar Gum - an antioxidant. In addition, the Company has its alkaline water system.

Umatrin Holding Limited (UMHL), closed Tuesday's trading session at $0.03, up 16.28%, on 11,050 volume with 3 trades. The average volume for the last 60 days is 17,010 and the stock's 52-week low/high is $0.012/$0.08.

chart

The QualityStocks Company Corner

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announced that it has retained Link Media LLC ("Link Media") to provide communications and market awareness services to the Company, aimed at maintaining and building the profile of PreveCeutical among existing and potential investors.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.05, up 40.85%, on 11,338,130 volume with 1,585 trades. The average volume for the last 60 days is 24,257 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

GreenBox POS, LLC (OTCQB: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (GreenBox) (OTCQB:GRBX), a hardware and software technology company that builds customized payment solutions for a multitude of industries, announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.25, up 31.58%, on 123,005 volume with 26 trades. The average volume for the last 60 days is 17,017 and the stock's 52-week low/high is $0.017/$0.56.

Recent News

chart

First Cobalt Corp. (TSX-V: FCC) (OTCQX: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce that drilling in the Canadian Cobalt Camp has identified a second cobalt mineralization trend within the Kerr area near surface extending over a 500-metre strike length. This mineralized trend is located parallel to and 400 metres north of the previously identified Kerr #2 Zone, which has been traced over 350 metres to date.

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.3539, up 15.69%, on 290,535 volume with 121 trades. The average volume for the last 60 days is 191,295 and the stock's 52-week low/high is $0.2644/$1.3041.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE) (OTC: PQEFF) (FSE: A2DYWC) ("Petroteq" or the "Licensee"), a company focused on the development and implementation of proprietary technologies for the energy industry, announced an agreement with Cavitation Technologies, Inc (OTCQB: CVAT) (Berlin: WDC) (“CTi” or the “Licensor”), a company providing highly scalable and cost-effective solutions to various fluids processing industries. Also today, PQEFF this morning announced that it has entered into a licensing agreement with Cavitation Technologies, Inc. (OTCQB: CVAT) (Berlin: WDC) (“CTi”) to test its equipment during oil production for workflow efficiencies and to lower its cost of production obtained through Petroteq’s oil sands extraction process. To view the full press release, visit: http://nnw.fm/5I5rU.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.08993, up 14.89%, on 1,176,135 volume with 951 trades. The average volume for the last 60 days is 124,178 and the stock's 52-week low/high is $0.28/$1.8892.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC:NUGL) (the “Company”), the cannabis industry's new standard of technology, today announces it has hired Thomas Bouse, CPA, as the new Chief Financial Officer (“CFO”) of NUGL Inc. Bouse will replace Brandon Vargas who has been acting interim CFO. NUGL’s appointment of a highly qualified CFO is strategically tied to the Company’s ongoing financial audit.

NUGL Inc. (OTC: NUGL), is a search engine and online directory for the marijuana industry. NUGL’s database includes listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands. The company focuses on leading the evolution in business relations, development and organic data in the cannabis industry with metasearch technology.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.23, up 4.24%, on 195,525 volume with 206 trades. The average volume for the last 60 days is 92,917 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

Zenosense, Inc. (OTCQB: ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Zenosense, Inc. (OTCQB: ZENO), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held device for the early detection of heart attack at the Point of Care, is pleased to announce that the Company is now trading on the OTC Markets Group OTCQB “Venture Market”. Investors can find current financial disclosure, company news and Real-Time Level 2 quotes for Zenosense at:   http://www.otcmarkets.com/stock/ZENO/quote.

Zenosense, Inc. (OTCQB: ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.40055, up 5.13%, on 128,306 volume with 67 trades. The average volume for the last 60 days is 266,839 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

EVIO, Inc. (OTCQB: EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO Inc. (OTCQB: EVIO) ("EVIO" or "the Company") a leading provider of cannabis testing and scientific research for the regulated cannabis industry, today announced that it has expanded its footprint in California by signing a 5-year lease agreement for a 7,370 square foot facility in Palm Desert, Calif.

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.08, even for the day, on 53,423 volume with 57 trades. The average volume for the last 60 days is 99,993 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Earth Science Tech, Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTC: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, is pleased to share progress on the company’s CBD IP patent formula development program.

Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.795, up 6.00%, on 12,044 volume with 10 trades. The average volume for the last 60 days is 12,301 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

WhereverTV Broadcasting Corp. (OTCQB: TVTV)

The QualityStocks Daily Newsletter would like to spotlight WhereverTV Broadcasting Corp. (TVTV).

WhereverTV Broadcasting Corp. (OTCQB:TVTV), a provider of next-generation Internet television solutions, announces it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

WhereverTV Broadcasting Corp. (OTC: TVTV) is a next-generation OTT (Over-the-top) television subscription service that manages live-stream broadcast programming rights across multiple devices, geographies and languages, providing viewers with personalized service that is truly “wherever” they may be watching TV.

WhereverTV’s patented Interactive Program Guide (IPG) technology currently handles over 125 live channels that are broadcasted securely over the Internet to any Internet-enabled device anywhere in the world. Many of the company’s channels are the same as those broadcasted by traditional cable and satellite companies. For example, the World News Now package includes One America News, RT News (Russia Today), Bloomberg TV, CBN News and EuroNews Live — the latter provides pan-European coverage in 350 million households in 155 countries. Other channel packages include Choice TV (a wide variety of popular options for the family), Spanish TV, Faith TV and Morocco TV, providing current genre-specific subscriptions for news, faith, drama, sports, movie, reality and children’s programming.

WhereverTV’s free app works with iOS and Android devices to cover the spectrum of mobile consumer needs, as well as with personal desktop or laptop computers through its over the top (OTT) platform. The platform delivers channels, shows and events to SmartTVs and digital media receivers that include Google Chromecast, AppleTV, Amazon Fire TV, iPhone, iPad, Android Smartphone and TabletPCs, with DVR recording functionality slated for future development.

The company, based in Fort Myers, Florida, was developed in 2007 as a solution to its founder’s frustration with the complexities of trying to stream English speaking content while abroad. As the live-streaming market has developed over the decade since then, WhereverTV has gained recognition as a pioneer in next-generation content delivery systems.

WhereverTV’s strategy is to increase revenue-generating subscriptions worldwide through the acquisition of content that is desirable to consumers and deliverable anywhere a device can connect to the Internet. Prepaid accounts will be accessed through the cloud, and the IPG technology will allow users to make their viewing choices. The company has developed two separate divisions, one for worldwide distribution and one for Latin American distribution.

In 2017, the company acquired Digital Rodeo, LLC, a Tennessee limited liability company that delivers a rich mixture of music and videos from independent country artists, current arrests and legacy artists, as well as similar Florida-based companies Digital RodeoTV, LLC (Name changed to WhereverTV Country in 2018), Digital CrossTV, Inc., Digital PopTV, Inc., and Digital RockTV, Inc.

WhereverTV is transitioning from a development to operational company and in doing so we have refined our 2018 business model,” CEO Edward D. Ciofani stated. “Our business model calls for content acquisition from around the world, exclusive content development, Major Marketing Alliances, similar to the announced Google Chromecast for Latin America and major marketing initiatives including social media marketing. … There are a lot of content providers (channel providers) around the world that offer a uniquely diversified perspective of cultures, travel and lifestyle content.”

As an increasing number of people “Cord-Cutters” no longer subscribe to the traditional cable or satellite distribution but rather a simpler lower cost means of watching content. The streaming OTT industry is expected to grow to $62 billion by 2020 — nearly triple its revenues in 2015, per Goldman Small Cap Research. Future Market Insights estimated the North America OTT market alone at $16.29 billion in 2017 with a CAGR of 17.4 percent through 2028. The arrival of 5G technology this year has the potential to accelerate the pace.

WhereverTV Broadcasting Corp. (TVTV), closed the day's trading session at $0.0652, even for the day. The average volume for the last 60 days is 27,484 and the stock's 52-week low/high is $0.051/$0.46.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce that it intends to spin out its Canadian assets into a separate Canadian entity and apply to list the shares on the Toronto Stock Exchange (“TSX”) and the NASDAQ Stock Market (“NASDAQ”) in an effort to unlock the underlying value of the Company’s assets on both sides of the border (the “Spinout Transaction”).

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.10, off by 0.54%, on 41,338 volume with 143 trades. The average volume for the last 60 days is 35,975 and the stock's 52-week low/high is $5.7358/$16.00.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO; OTCQB: CHOOF) (the "Company" or "Choom"), an emerging fully-integrated cannabis company, is pleased to announce the appointment of Aussie Jiwani to the Management team as Director of Sales.  Mr. Jiwani will be a crucial member of the Choom team as we move towards being a cultivator of premium craft cannabis and the leading cannabis retailer for the recreational market in Canada.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.9249, up 1.30%, on 195,575 volume with 229 trades. The average volume for the last 60 days is 564,089 and the stock's 52-week low/high is $0.18/$1.10.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF) a royalty company for the U.S. licensed medical cannabis industry, has executed an Expanded Royalty Agreement with Refined Resin Technologies Inc. (“Refined Resin”) formerly known as Gram Co Holdings LLC, of Oakland, California.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.2421, up 5.31%, on 37,255 volume with 42 trades. The average volume for the last 60 days is 205,281 and the stock's 52-week low/high is $0.18/$0.8612.

Recent News

chart

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)

The QualityStocks Daily Newsletter would like to spotlight Victory Square Technologies Inc. (VSQTF).

Supporting its strategic vision for a vertically-integrated media division and entertainment hub, Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to report on the results from its second quarter acquisition of V2 Games Inc. (“V2 Games”).

Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.

Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.

A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.

Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.

“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”

Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.

“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”

A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.

The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.

In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.

“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.

Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.

Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.

“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”

Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.

Victory Square Technologies Inc. (VSQTF), closed the day's trading session at $0.629, off by 11.97%, on 18,800 volume with 27 trades. The average volume for the last 60 days is 29,425 and the stock's 52-week low/high is $0.298/$3.32.

Recent News

chart

GTX Corp (OTC: GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with GTX Corp (OTC:GTXO), a client of NNW engaged in the manufacturing and commercialization of various innovative GPS tracking and recovery products and services. The interview can be heard at http://nnw.fm/9KCtB. Also today, NetworkNewsWire released a report on the company detailing how GTXO has created a range of tracking technologies that provide comfort and safety and make it a pioneer in the GPS wearables market. Its premier product is the award-winning GPS SmartSole®, which is the world’s first invisible wearable tracking device designed specifically for people at risk of becoming lost or disoriented.

GTX Corp (OTC: GTXO) designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://nnw.fm/mrcV2), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.0014, off by 26.32%, on 32,634,406 volume with 76 trades. The average volume for the last 60 days is 5,460,986 and the stock's 52-week low/high is $0.0011/$0.0089.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.